Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Annals of the New York Academy of Sciences
|
January 31, 2004
HER-2-targeted antisense oligonucleotide results in sensitization of head and neck cancer cells to chemotherapeutic agents
Antonina S Rait, Kathleen F Pirollo, David Ulick, et al.
Oncoimmunology
|
October 6, 2018
Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor
Sang-Soo Kim, Joe B Harford, Manish Moghe, et al.
International Journal of Nanomedicine
|
March 16, 2026
Enhanced Delivery of Aurora Kinase A Inhibitor Alisertib via Tumor-Targeting Immunoliposome Nanocomplex for Improved Treatment of Cancers Including Atypical Teratoid/Rhabdoid Tumor
Sang-Soo Kim, Manish Moghe, Antonina S Rait, et al.
International Journal of Cancer
|
June 27, 2019
A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma
Sang-Soo Kim, Joe B Harford, Manish Moghe, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 5, 2008
Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo
Chengli Yang, Antonina Rait, Kathleen F Pirollo, et al.
Molecular Cancer Therapeutics
|
January 7, 2005
Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment
Mona S Jhaveri, Antonina S Rait, Koong-Nah Chung, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 1, 2016
Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study
Kathleen F Pirollo, John Nemunaitis, Po Ki Leung, et al.
International Journal of Nanomedicine
|
June 19, 2024
SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors
Sang-Soo Kim, Manish Moghe, Antonina Rait, et al.
Cancer Letters
|
September 2, 2015
Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma
Sang-Soo Kim, Antonina Rait, Eric Kim, et al.
Nucleic Acids Research
|
December 5, 2017
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
Sang-Soo Kim, Joe B Harford, Manish Moghe, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Annals of the New York Academy of Sciences
|
January 31, 2004
HER-2-targeted antisense oligonucleotide results in sensitization of head and neck cancer cells to chemotherapeutic agents
Antonina S Rait, Kathleen F Pirollo, David Ulick, et al.
Oncoimmunology
|
October 6, 2018
Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor
Sang-Soo Kim, Joe B Harford, Manish Moghe, et al.
International Journal of Nanomedicine
|
March 16, 2026
Enhanced Delivery of Aurora Kinase A Inhibitor Alisertib via Tumor-Targeting Immunoliposome Nanocomplex for Improved Treatment of Cancers Including Atypical Teratoid/Rhabdoid Tumor
Sang-Soo Kim, Manish Moghe, Antonina S Rait, et al.
International Journal of Cancer
|
June 27, 2019
A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma
Sang-Soo Kim, Joe B Harford, Manish Moghe, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 5, 2008
Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo
Chengli Yang, Antonina Rait, Kathleen F Pirollo, et al.
Molecular Cancer Therapeutics
|
January 7, 2005
Antisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment
Mona S Jhaveri, Antonina S Rait, Koong-Nah Chung, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 1, 2016
Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study
Kathleen F Pirollo, John Nemunaitis, Po Ki Leung, et al.
International Journal of Nanomedicine
|
June 19, 2024
SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors
Sang-Soo Kim, Manish Moghe, Antonina Rait, et al.
Cancer Letters
|
September 2, 2015
Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma
Sang-Soo Kim, Antonina Rait, Eric Kim, et al.
Nucleic Acids Research
|
December 5, 2017
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
Sang-Soo Kim, Joe B Harford, Manish Moghe, et al.
Page
of 5